✦ LIBER ✦

Ro 22-9194: A New Class I Antiarrhythmic Agent

✍ Scribed by Murakami, Makoto ;Furukawa, Yasuyuki ;Nakashima, Mitsuyoshi ;Chiba, Shigetoshi

Book ID: 109105934
Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 647 KB
Volume: 14
Category: Article
ISSN: 0897-5957
DOI: 10.1111/j.1527-3466.1996.tb00313.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bisaramil, A New Class I Antiarrhythmic

Bisaramil, A New Class I Antiarrhythmic Agent

✍ Hiraoka, Masayasu ;Sunami, Akihiko ;Tajima, Kiyotaka 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

Pilsicainide, a New Class I Antiarrhythm

Pilsicainide, a New Class I Antiarrhythmic Drug

✍ Hashimoto, Hisakuni ;Nakashima, Mitsuyoshi 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

Initial clinical experience of lorcainid

Initial clinical experience of lorcainide (Ro 13-1042), a new antiarrhythmic agent

✍ G. Cocco; C. Strozzi 📂 Article 📅 1978 🏛 Springer 🌐 English ⚖ 303 KB

ChemInform Abstract: A New Class of Anti

ChemInform Abstract: A New Class of Antiarrhythmic-Defibrillatory Agents.

✍ Ofra Levy; Mordechai Erez; Dalia Varon; Ehud Keinan 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 1 views

Pharmacological effects of Ro 22-1319: A

Pharmacological effects of Ro 22-1319: A new antipsychotic agent

✍ Arnold B. Davidson; Edward Boff; Donald A. MacNeil; James Wenger; Leonard Cook 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 844 KB

Ro 22-1319, a novel pyrroloisoquinoline compound, was identified as a potential antipsychotic agent in a rat discrete avoidance procedure that is highly specific for such agents. Results in this test are highly correlated with the clinical potency of all types of antipsychotic agents. The avoidance-

Effect of SC-40230, a new class I antiar

Effect of SC-40230, a new class I antiarrhythmic agent, on canine ventricular tachycardias

✍ S. Garthwaite; Frida Hatley; Leo Frederick; Jeanette Ruby; Chyung Cook 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 975 KB

SC-40230, a-[2-[acetyl( 1 -methylethyl) amino]ethyl]-tr-(2-chlorophenyl)-l -piperidinebutanamide, a new class I antiarrhythmic agent, was tested for efficacy against coronary ligation-induced arrhythmias and ouabain toxicity arrhythmias in dogs. Doses of 9 mg/kg i.v. and 15, 25, and 35 mgikg p.0. s